Clinical trials

  • IOHEXOL for Acute abdomen | Impaired renal function (eGFR 15-45 ml/min/1.73 m2)
  • Adipose-derived stromal vascular fraction (autologous) for Inclusion body myositis
  • LEVOCARNITINE, MAGNESIUM CHLORIDE HEXAHYDRATE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, GLUCOSE MONOHYDRATE, SODIUM LACTATE for End-stage kidney disease
  • BETAMETHASONE SODIUM PHOSPHATE for Multiple myeloma | Relapsed multiple myeloma
  • Progesterone, micronised for Insomnia|Climacteric symptoms
  • TALDEFGROBEP ALFA for Spinal muscular atrophy
  • Clinical trial in Advanced solid tumor
  • FLUTEMETAMOL (18F) for Alzheimer's disease|Progressive supranuclear palsy|Frontotemporal dementia|Corticobasal degeneration|Mild cognitive impairment
  • AVELUMAB for Head and neck squamous cell carcinoma (recurrent/metastatic)
  • TREMELIMUMAB for Malignant mesothelioma | Pleural mesothelioma | Peritoneal mesothelioma
  • NADUNOLIMAB for Triple-negative breast cancer|Advanced triple-negative breast cancer
  • Tarlatamab for Extensive stage small cell lung cancer